INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines - RBGLY
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt Benckiser Group Plc (“Reckitt” or the “Company”)(OTC: RBGLY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Reckitt and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until August 4, 2025 to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Reckitt securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
On March 15, 2024, an Illinois jury returned a $60 million verdict in a lawsuit against Reckitt’s Mead Johnson subsidiary. The jury specifically found that Mead Johnson was negligent in failing to warn that consuming Mead Johnson’s cow’s milk-based formula increased the risk of necrotizing enterocolitis (“NEC”) in preterm infants.
On this news, Reckitt’s American Depositary Share (“ADS”) price fell $1.87 per share, or nearly 14%, to close at $11.44 per share on March 15, 2024.
Then, on July 29, 2024, a Missouri jury awarded a $495 million in a similar lawsuit against Abbott Laboratories, Inc. (“Abbott”), making similar findings regarding Abbott’s specialized baby formula and the risk of NEC.
On this news, Reckitt’s ADS price fell $1.02 per share, or nearly 9%, to close at $10.64 per share on July 29, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
